Ignite Creation Date:
2025-12-24 @ 11:00 PM
Ignite Modification Date:
2025-12-25 @ 8:29 PM
Study NCT ID:
NCT06185569
Status:
RECRUITING
Last Update Posted:
2023-12-29
First Post:
2023-10-16
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
FREDO-ODX Study: FREnch Data on Outcomes in HR+/HER2- Early Breast Cancer Patients With oncotypeDX Recurrence Score-guided Therapy
Sponsor:
Centre Hospitalier Universitaire de Besancon
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-10-15
Start Date Type:
ACTUAL
Primary Completion Date:
2028-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-03
Completion Date Type:
ESTIMATED
First Submit Date:
2023-10-16
First Submit QC Date:
None
Study First Post Date:
2023-12-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-14
Last Update Post Date:
2023-12-29
Last Update Post Date Type:
ACTUAL